MNCs Can Access Asian Markets Faster With Bridging Studies – Parexel Exec
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Global studies that include Asia should be part of any multinational company's strategy to accelerate development time and gain access to the Asian market, a Parexel exec told the recent BioMedical Asia conference in Singapore